← Evidence map

ArticleClinics (Sao Paulo, Brazil)2026

Gut mycobiome in the spectrum of Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD): from MASH to hepatocellular carcinoma.

Cássio Marques Perlin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Gut mycobiome in the spectrum of Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD): from MASH to hepatocellular carcinoma. | OpenQuestion